Literature DB >> 26608187

Normal systemic iron homeostasis in mice with macrophage-specific deletion of transferrin receptor 2.

Gautam Rishi1, Eriza S Secondes2, Daniel F Wallace1, V Nathan Subramaniam3.   

Abstract

Iron is an essential element, since it is a component of many macromolecules involved in diverse physiological and cellular functions, including oxygen transport, cellular growth, and metabolism. Systemic iron homeostasis is predominantly regulated by the liver through the iron regulatory hormone hepcidin. Hepcidin expression is itself regulated by a number of proteins, including transferrin receptor 2 (TFR2). TFR2 has been shown to be expressed in the liver, bone marrow, macrophages, and peripheral blood mononuclear cells. Studies from our laboratory have shown that mice with a hepatocyte-specific deletion of Tfr2 recapitulate the hemochromatosis phenotype of the global Tfr2 knockout mice, suggesting that the hepatic expression of TFR2 is important in systemic iron homeostasis. It is unclear how TFR2 in macrophages contributes to the regulation of iron metabolism. We examined the role of TFR2 in macrophages by analysis of transgenic mice lacking Tfr2 in macrophages by crossing Tfr2(f/f) mice with LysM-Cre mice. Mice were fed an iron-rich diet or injected with lipopolysaccharide to examine the role of macrophage Tfr2 in iron- or inflammation-mediated regulation of hepcidin. Body iron homeostasis was unaffected in the knockout mice, suggesting that macrophage TFR2 is not required for the regulation of systemic iron metabolism. However, peritoneal macrophages of knockout mice had significantly lower levels of ferroportin mRNA and protein, suggesting that TFR2 may be involved in regulating ferroportin levels in macrophages. These studies further elucidate the role of TFR2 in the regulation of iron homeostasis and its role in regulation of ferroportin and thus macrophage iron homeostasis.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  hepcidin; iron metabolism; macrophages

Mesh:

Substances:

Year:  2015        PMID: 26608187     DOI: 10.1152/ajpgi.00291.2015

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  6 in total

1.  Transferrin receptor 1-mediated iron uptake regulates bone mass in mice via osteoclast mitochondria and cytoskeleton.

Authors:  Bhaba K Das; Lei Wang; Toshifumi Fujiwara; Jian Zhou; Nukhet Aykin-Burns; Kimberly J Krager; Renny Lan; Samuel G Mackintosh; Ricky Edmondson; Michael L Jennings; Xiaofang Wang; Jian Q Feng; Tomasa Barrientos; Jyoti Gogoi; Aarthi Kannan; Ling Gao; Weirong Xing; Subburaman Mohan; Haibo Zhao
Journal:  Elife       Date:  2022-06-27       Impact factor: 8.713

2.  Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model.

Authors:  Irene Artuso; Maria Rosa Lidonnici; Sandro Altamura; Giacomo Mandelli; Mariateresa Pettinato; Martina U Muckenthaler; Laura Silvestri; Giuliana Ferrari; Clara Camaschella; Antonella Nai
Journal:  Blood       Date:  2018-09-12       Impact factor: 22.113

3.  Postmenopausal Iron Overload Exacerbated Bone Loss by Promoting the Degradation of Type I Collagen.

Authors:  Qian Cheng; Xiaofei Zhang; Jun Jiang; Guoyang Zhao; Yin Wang; Youjia Xu; Ximing Xu; Haile Ma
Journal:  Biomed Res Int       Date:  2017-05-23       Impact factor: 3.411

4.  Evidence for dimerization of ferroportin in a human hepatic cell line using proximity ligation assays.

Authors:  Gautam Rishi; Eriza S Secondes; Daniel F Wallace; V Nathan Subramaniam
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

5.  Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signaling.

Authors:  Martina Rauner; Ulrike Baschant; Antonella Roetto; Rosa Maria Pellegrino; Sandra Rother; Juliane Salbach-Hirsch; Heike Weidner; Vera Hintze; Graeme Campbell; Andreas Petzold; Regis Lemaitre; Ian Henry; Teresita Bellido; Igor Theurl; Sandro Altamura; Silvia Colucci; Martina U Muckenthaler; Georg Schett; Davide Komla Ebri; J H Duncan Bassett; Graham R Williams; Uwe Platzbecker; Lorenz C Hofbauer
Journal:  Nat Metab       Date:  2019-01-07

Review 6.  Transferrin Receptors in Erythropoiesis.

Authors:  Cyrielle Richard; Frédérique Verdier
Journal:  Int J Mol Sci       Date:  2020-12-19       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.